Fox Run Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159K | Sell |
|
|||||
|
2025
Q1 | $221K | Sell |
|
|||||
|
2024
Q4 | $512K | Buy |
|
|||||
|
2024
Q3 | $309K | Buy |
|
|||||
|
2024
Q2 | $223K | Buy |
|
|||||
|
2024
Q1 | $94.1K | Sell |
|
|||||
|
2023
Q4 | $114K | Sell |
|
|||||
|
2023
Q3 | $180K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $250K | Buy |
|
|||||
|
2022
Q2 | $157K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $123K | Buy |
|
|||||
|
2017
Q2 | $126K | Buy |
|